- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02711540
Retrospective Analysis of Procedural Aspects of Transcatheter Aortic Valve Implantation (TAVI) on Peri-procedural Stroke
Retrospective Analysis of Procedural Aspects of Transcatheter Aortic Valve Implantation (TAVI) on Peri-procedural Stroke Rates in the United Kingdom
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Retrospective analysis of all patients receiving TAVI in the UK. Stroke rates following TAVI are roughly 3%. There are several device and procedure related characteristics which may increase the risk of stroke. We will examine if there is a signal in the UK registry. This will be important is TAVI is to be extended down to lower risk patient cohorts.
Factors to be examined include (but not limited to):
need for Pre-procedure Balloon aortic Valvuloplasty (BAV) Need for two valves need for post-dilatation need for rapid ventricular burst pacing
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Had TAVI procedure in UK
Exclusion Criteria:
- Nil
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pre-TAVI Balloon Aortic Valvuloplasty
This is the cohort of patients in the study who did receive Balloon Aortic Valvuloplasty (BAV) prior to TAVI implantation
|
Some patients receive BAV prior to TAVI implantation to facilitate better deployment of the TAVI valve
|
|
No Pre-TAVI Balloon Aortic Valvuloplasty
This is the cohort of patients in the study who did not receive Balloon Aortic Valvuloplasty (BAV) prior to TAVI implantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stroke
Time Frame: 30 days
|
Stroke, defined as new neurological deficit with corresponding change on CT scan of brain, is a self reported event following TAVI.
All centres performing TAVI in the United Kingdom are required to report this to the National Institute for Cardiovascular Outcomes Research (NICOR) registry which is being analysed in this study
|
30 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TAVIStrokePredictors
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Valve Stenosis
-
Azienda Ospedaliera "Sant'Andrea"University of Bologna; Politecnico di Milano; Centro Cardiologico Monzino; I.R.C...RecruitingAortic Stenosis | Calcific Aortic Valve Disease | Chronic Coronary Syndrome | Calcific Aortic StenosisItaly
-
National Institute of Cardiology, Warsaw, PolandThe Institute of Bioorganic Chemistry, Polish Academy of SciencesRecruitingAortic Stenosis | Low-gradient Aortic StenosisPoland
-
Chinese Academy of Medical Sciences, Fuwai HospitalEdwards (Shanghai) Lifesciences Medical Supplies Co., Ltd.Not yet recruiting
-
MiRusRecruitingAortic Stenosis | Symptomatic Severe Native Aortic StenosisUnited States
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
Hospital Universitari Vall d'Hebron Research InstituteNot yet recruitingCardiovascular Diseases | Severe Aortic Valve StenosisSpain
-
RenJi HospitalRecruitingSevere Aortic Valve StenosisChina
-
Shanghai MicroPort CardioFlow Medtech Co., Ltd.CompletedSevere Aortic Stenosis | Transcatheter Aortic Valve ReplacemenChina
-
Anteris Technologies Ltd.Active, not recruitingAortic Valve Disease | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic Stenosis | Aortic Valve FailureDenmark
-
Idoven 1903 S.L.Recruiting
Clinical Trials on Balloon Aortic Valvuloplasty
-
University of California, San FranciscoCompletedAortic Stenosis | Hypoplastic Left Heart SyndromeUnited States
-
University Hospital of FerraraCompleted
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknown
-
InterValve, Inc.CompletedAortic Valve StenosisUnited States
-
Opsens, Inc.Terminated
-
National and Kapodistrian University of AthensCompletedAortic Valve StenosisGreece, Israel
-
Medstar Health Research InstituteTerminatedAortic Valve Stenosis
-
Edwards LifesciencesCompletedCritical Aortic StenosisUnited States, Canada, Germany
-
Spectranetics CorporationCompleted
-
Community Memorial Health SystemRecruitingAortic Valve StenosisUnited States